/** blogpostTitle: Praj Industries in FY26: Execution headwinds, a weaker profit year, and the next bets on Bio-IBA and modularization */

Praj Industries in FY26: Execution headwinds, a weaker profit year, and the next bets on Bio-IBA and modularization

Praj Industries closed FY26 with a mixed picture. The company remained a visible player in bioenergy engineering, backed by a large global reference base and an order backlog of INR 4,305 crore as of Q4 FY26. But financial performance weakened sharply.

On a consolidated basis, operational income for FY26 was INR 3,167.9 crore versus INR 3,228.0 crore in FY25. Profitability fell more meaningfully. EBITDA declined to INR 151.8 crore with EBITDA margin at 4.79 percent. PAT dropped to INR 23.8 crore, with PAT margin at 0.75 percent. Management attributed much of the pressure to execution-related cost escalation and extended project cycles, rather than a one-dimensional raw material shock.

The FY26 revenue mix continued to be led by bioenergy. Bioenergy contributed 67 percent of revenue at INR 2,142.3 crore. Engineering contributed 22 percent at INR 693.1 crore, and High Purity Solutions (PHS) contributed 11 percent at INR 332.6 crore. Export revenues were stated at 36 percent for FY26.

What hurt FY26 results: delays, site costs, and a cautious booking stance

In the Q4 and FY26 earnings call, management repeatedly returned to one operational theme: execution cycles got extended. Funding and other challenges at customer sites led to projects staying open longer. The CFO said that more than raw material prices, cost escalation in site execution was the key factor because delayed closures increased site-related expenses.

There was also an explicit reference to procurement uncertainty. Management noted that it deferred final negotiations for a set of opportunities due to uncertainties around raw material costs and supply chain disruptions. It described this not as confirmed orders but an inquiry basket, quantified at about INR 300 crore plus, that was not finalized in Q4 FY26.

These operating realities are visible in the company’s longer-term working capital profile shown in the presentation, with working capital days at 91 in FY26, similar to 90 in FY25.

Segment lens: core bioenergy remains dominant, but the next growth triggers are shifting

Praj’s positioning is built on long standing exposure to ethanol and biofuels. Management highlighted that India’s biofuels ecosystem is moving from policy intent toward commercial market readiness, supported by coordinated actions by government bodies, oil marketing companies, auto manufacturers, technology providers, and producers.

A key development repeatedly referenced in the call was the Bureau of Indian Standards notifying fuel specifications for E22, E25, E27, and E30 petrol blends, in addition to E85 and E100. Management also cited a government roadmap for E85 and E100 retail outlets, beginning with 150 outlets in select cities within the next month, scaling to 500 in 6 to 12 months, and targeting 5,000 E100 dispensing stations nationwide within 24 months.

For Praj’s domestic 1G ethanol business, management acknowledged a slowdown in greenfield fuel ethanol projects. In the interim, it pointed to two pockets of demand: greenfield ENA plants where it claims a technology edge, and brownfield solutions focused on operational efficiency and co-products such as distiller’s corn oil.

In 2G, management stated that three commercial-scale 2G bio-refineries are being deployed in India and asserted that all three are being executed by Praj. It also linked 2G ethanol to the long-term sustainable aviation fuel opportunity.

For compressed biogas (CBG), management spoke about capacity ramp-up underway at some plants using mixed feedstock like Napier grass and rice straw. It also referenced Maharashtra’s State CBG Policy 2026 with an outlay of INR 500 crore, aimed at scaling waste-to-energy and circular economy infrastructure.

GenX and modularization: the big fixed-cost bet that needs utilization

A notable strategic thread in the earnings call was Praj GenX. Management acknowledged that it has been investing for the last two and a half to three years to make the Mangalore facility ready for large-scale modular solutions. This has come with a gestation period.

The CFO quantified the fixed overhead run rate for GenX at about INR 10 crore per month. This number is important because it frames the utilization challenge. Until GenX reaches a steady order and execution cadence, profitability can remain sensitive.

Management also described a course correction. It said the energy transition and climate action segment, which included areas like electrolyzers, had become subdued over the last two years. In response, the company pivoted to segments where modular fabrication demand is more active, including data centers, LNG, and conventional oil and gas.

For data centers, management said it is in final discussions with a key customer for modularized cooling system solutions for international data centers. It indicated that order values can vary from INR 50 crore to INR 150 crore depending on size, and it expects some good news in Q1 FY27. It also disclosed that 12 to 13 customers have cleared the Mangalore facility, up from around nine at the end of Q3.

SAF and Bio-IBA: a near-term commercialization marker and a longer-term policy-led market

Praj’s investor presentation and call both positioned sustainable aviation fuel (SAF) as an emerging opportunity. Management said a draft SAF policy is ready and blending mandates are expected to come in 2027.

On the project front, the company stated it is completing a basic engineering order for one ethanol-to-SAF plant for an international customer and is in discussions for the detailed engineering order.

A nearer-term commercialization marker could be bio-isobutanol (Bio-IBA). Management said Bio-IBA technology is ready for commercialization and scale-up and expects the first order in the current quarter of FY27. It also highlighted the larger volume potential for diesel blending versus petrol blending.

Financial snapshot

Note: Values are converted from INR million to INR crore.

What to track into FY27

Management’s FY27 messaging was cautious but directional. It expects the external environment to remain uncertain, but it also suggested that the worst of the FY26 execution-related margin pressure is largely behind, as the mix shifts from longer greenfield cycles toward smaller brownfield projects.

The practical monitorables for FY27 are clear from the disclosures. One is whether deferred negotiations translate into actual order intake without forcing uneconomic fixed-price exposure. Another is whether GenX can book and execute enough modularization work to absorb a stated fixed overhead base. And finally, whether the expected first Bio-IBA order materializes within the stated timeframe, creating a tangible commercialization proof point.

Praj’s presentation continues to emphasize technology depth, long reference history, and an expanding opportunity set across biofuels, CBG, SAF, and modular engineering. FY26, however, showed that execution timelines and cost control are decisive in translating that positioning into shareholder outcomes. FY27 will likely be judged on whether order visibility converts into cleaner project closures and more stable margins.